Universitätsklinikum Würzburg

Idecabtagene vicleucel in relapsed and refractory multiple myeloma (2021) Munshi NC, Anderson LD, Shah N, Madduri D, Berdeja J, Lonial S, Raje N, et al. Journal article Evaluation of plaque characteristics and inflammation using magnetic resonance imaging (2021) Andelovic K, Winter P, Jakob PM, Bauer WR, Herold V, Zernecke A Journal article Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Third interim analysis from the RIBANNA study (2021) Wockel A, Brucker C, Decker T, Falbrede J, Forstbauer H, Gohler T, Hoffmann O, et al. Conference contribution Direct Visualization of Fungal Burden in Filamentous Fungus-Infected Silkworms (2021) Yu Y, Wolf AK, Thusek S, Heinekamp T, Bromley M, Krappmann S, Terpitz U, et al. Journal article Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial (2021) Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, et al. Journal article A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease (2021) Baeuerlein CA, Qureischi M, Mokhtari Z, Tabares P, Brede C, Garrote ALJ, Riedel SS, et al. Journal article The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis (2021) Mytilineos D, Tsamadou C, Neuchel C, Platzbecker U, Bunjes D, Schub N, Wagner-Drouet E, et al. Journal article A Management Algorithm for Stomach Pain in Family Practice: One Result of the ‘Seminartage Weiterbildung Allgemeinmedizin’ (SemiWAM®) Ein Algorithmus zum Umgang mit Bauchschmerz in der Hausarztpraxis: Ein Ergebnis der Seminartage Weiterbildung Allgemeinmedizin (SemiWAM®) (2021) Schneider D, Simmenroth A, Roos M Journal article CD8+ T cells in atherosclerosis (2021) Schaefer S, Zernecke A Journal article, Review article Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (2021) Garcia-Guerrero E, Goetz R, Doose S, Sauer M, Rodriguez-Gil A, Nerreter T, Kortuem KM, et al. Journal article